Big Pharma Carves out a New Market for a Dangerous Breast Cancer Drug

An industry-funded movement is afoot to put healthy women on bone-thinning and heart-risky drugs to prevent cancer. Celeste McGovern investigates the conventional advice and better alternatives. Most people have never heard of aromatase inhibitors even though they’ve been used for years to prevent breast-cancer tumour regrowth among women who’ve already been diagnosed and treated for […]

Continue reading